MA28801B1 - Composition antihistaminique - Google Patents

Composition antihistaminique

Info

Publication number: MA28801B1
Authority: MA; Morocco
Prior art keywords: antihistamine composition; antihistamine; composition
Prior art date: 2004-07-16

Application number

MA29679A

Other languages

English (en)

Inventor

Amar Lulla

Geena Malhotra

Sankarnarayanan Anand

Original Assignee

Cipla Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-16

Filing date

2007-02-13

Publication date

2007-08-01

2007-02-13 Application filed by Cipla Ltd filed Critical Cipla Ltd

2007-08-01 Publication of MA28801B1 publication Critical patent/MA28801B1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MA29679A 2004-07-16 2007-02-13 Composition antihistaminique MA28801B1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IN765MU2004		2004-07-16

Publications (1)

Publication Number	Publication Date
MA28801B1 true MA28801B1 (fr)	2007-08-01

Family

ID=35539416

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29679A MA28801B1 (fr)	2004-07-16	2007-02-13	Composition antihistaminique

Country Status (16)

Country	Link
US (1)	US20070281960A1 (fr)
EP (1)	EP1778195A2 (fr)
JP (1)	JP2008506679A (fr)
KR (1)	KR20070053221A (fr)
AP (1)	AP2007003915A0 (fr)
AU (1)	AU2005263958B2 (fr)
BR (1)	BRPI0513417A (fr)
CA (1)	CA2574188A1 (fr)
EC (1)	ECSP077262A (fr)
IL (1)	IL180724A0 (fr)
MA (1)	MA28801B1 (fr)
MX (1)	MX2007000632A (fr)
NZ (1)	NZ552998A (fr)
TN (1)	TNSN07013A1 (fr)
WO (1)	WO2006008512A2 (fr)
ZA (1)	ZA200701036B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK287105B6 (sk) *	1999-12-20	2009-12-07	Schering Corporation	Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
DK1698630T3 (da)	2005-03-03	2014-12-08	Alfa Wassermann Spa	Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
ITBO20050123A1 (it)	2005-03-07	2005-06-06	Alfa Wassermann Spa	Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
ITMI20061692A1 (it)	2006-09-05	2008-03-06	Alfa Wassermann Spa	Uso di polioli per ottenere forme polimorfe stabili di rifaximina
GB0702837D0 (en) *	2007-02-14	2007-03-28	Boc Group Plc	Method of treating a gas stream
CN101678012A (zh) *	2007-06-12	2010-03-24	阿尔克-阿贝洛有限公司	包含抗组胺药的过敏原剂型
TR200806298A2 (tr)	2008-08-22	2010-03-22	Bi̇lgi̇ç Mahmut	Farmasötik formülasyon
ES2709487T3 (es)	2010-05-10	2019-04-16	Lesvi Laboratorios Sl	Formulaciones farmacéuticas estables que contienen un antihistamínico
WO2012162439A2 (fr) *	2011-05-23	2012-11-29	Cem-102 Pharmaceuticals, Inc.	Compositions comprenant de l'acide fusidique et leurs emballages
CN109498585B (zh) *	2018-12-21	2019-09-10	扬子江药业集团广州海瑞药业有限公司	一种枸地氯雷他定片剂及其制备方法
JP7515533B2 (ja) *	2022-04-28	2024-07-12	沢井製薬株式会社	デスロラタジン含有フィルムコーティング錠剤
CN118924679B (zh) *	2024-07-24	2025-05-16	湖南派格兰药业有限公司	一种氨甲环酸凝胶组合物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1985003707A1 (fr) *	1984-02-15	1985-08-29	Schering Corporation	8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BD PYRIDINE ET SES SELS, LEURS PROCEDES DE PRODUCTION ET COMPOSITIONS PHARMACEUTIQUES CONTENANT SES COMPOSES
US5595997A (en) *	1994-12-30	1997-01-21	Sepracor Inc.	Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
TW522014B (en) *	1997-02-07	2003-03-01	Sepracor Inc	Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
US5939426A (en) *	1997-02-28	1999-08-17	Sepracor Inc.	Methods for treating urinary incontinence using descarboethoxyloratadine
ES2180976T3 (es) *	1997-04-25	2003-02-16	Schering Plough Kabushiki Kais	Colirio conteniendo un metabolito de loratidina.
US6506767B1 (en) *	1997-07-02	2003-01-14	Schering Corporation	8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
PT1380297E (pt) *	1998-07-10	2009-07-06	Schering Corp	Composições orais de 8-cloro-6,11-di-hidro-11-(4- piperidilideno)-5h-benzo[5,6]ciclo-hepta[1,2-b]piridina
US6100274A (en) *	1999-07-07	2000-08-08	Schering Corporation	8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
JP2006500038A (ja) *	2002-09-24	2006-01-05	ガムリンクエー／エス	低水分チューインガム
US20040258752A1 (en) *	2003-01-31	2004-12-23	Paruthi Manoj Kumar	Taste masking pharmaceutical composition and process for its preparation
CN100563654C (zh) *	2003-07-22	2009-12-02	范敏华	一种地氯雷他定分散片及其制备方法
GB2404336A (en) *	2003-07-30	2005-02-02	Cipla Ltd	Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
US7955620B2 (en) *	2003-12-23	2011-06-07	Sun Pharmaceutical Industries Limited	Stable oral composition

2005
- 2005-07-18 EP EP05761371A patent/EP1778195A2/fr not_active Withdrawn
- 2005-07-18 AP AP2007003915A patent/AP2007003915A0/xx unknown
- 2005-07-18 MX MX2007000632A patent/MX2007000632A/es not_active Application Discontinuation
- 2005-07-18 NZ NZ552998A patent/NZ552998A/en not_active IP Right Cessation
- 2005-07-18 US US11/572,175 patent/US20070281960A1/en not_active Abandoned
- 2005-07-18 ZA ZA200701036A patent/ZA200701036B/en unknown
- 2005-07-18 BR BRPI0513417-0A patent/BRPI0513417A/pt not_active IP Right Cessation
- 2005-07-18 JP JP2007520903A patent/JP2008506679A/ja active Pending
- 2005-07-18 AU AU2005263958A patent/AU2005263958B2/en not_active Ceased
- 2005-07-18 WO PCT/GB2005/002828 patent/WO2006008512A2/fr not_active Ceased
- 2005-07-18 KR KR1020077003510A patent/KR20070053221A/ko not_active Ceased
- 2005-07-18 CA CA002574188A patent/CA2574188A1/fr not_active Abandoned
2007
- 2007-01-16 TN TNP2007000013A patent/TNSN07013A1/en unknown
- 2007-01-16 IL IL180724A patent/IL180724A0/en unknown
- 2007-02-13 MA MA29679A patent/MA28801B1/fr unknown
- 2007-02-16 EC EC2007007262A patent/ECSP077262A/es unknown

Also Published As

Publication number	Publication date
AU2005263958B2 (en)	2011-04-14
WO2006008512A2 (fr)	2006-01-26
NZ552998A (en)	2010-11-26
EP1778195A2 (fr)	2007-05-02
AU2005263958A1 (en)	2006-01-26
TNSN07013A1 (en)	2008-06-02
IL180724A0 (en)	2007-07-04
WO2006008512A3 (fr)	2006-08-03
BRPI0513417A (pt)	2008-05-06
MX2007000632A (es)	2007-03-30
AP2007003915A0 (en)	2007-02-28
JP2008506679A (ja)	2008-03-06
ECSP077262A (es)	2007-03-29
CA2574188A1 (fr)	2006-01-26
US20070281960A1 (en)	2007-12-06
ZA200701036B (en)	2008-05-28
KR20070053221A (ko)	2007-05-23

Publication	Publication Date	Title
CY2019034I2 (el)	2019-11-27	4-φαινυλαμινο-κιναζολιν-6-υλ-αμιδια
EP1788047A4 (fr)	2011-12-21	Composition hydrofuge/oleofuge
ITMI20041252A1 (it)	2004-09-22	Composizioni perfluoroelastomeriche
ATE414693T1 (de)	2008-12-15	Neuartige cis-imidazoline
DE502005005035D1 (de)	2008-09-25	Wischblatt
MA28801B1 (fr)	2007-08-01	Composition antihistaminique
DE112005001624A5 (de)	2007-05-24	Brillengestell
DK2783682T3 (da)	2019-08-12	Farmaceutisk sammensætning omfattende pimobendan
ATE520680T1 (de)	2011-09-15	Hiv-hemmende 5-heterocyclylpyrimidine
ATE392425T1 (de)	2008-05-15	Thiazolyl-dihydro-indazole
DE502005004843D1 (de)	2008-09-04	Einspritzventil
ATE459633T1 (de)	2010-03-15	Makrolide
DE502005004842D1 (de)	2008-09-04	Wischblatt
DE602005016978D1 (de)	2009-11-12	Quecksilberfreisetzende Zusammensetzungen
DE112005000809A5 (de)	2007-05-24	Wankstabilisierungseinrichtung
DE602005017191D1 (de)	2009-11-26	Geruchsreduzierte waschstück-zusammensetzung
DE502004012213D1 (de)	2011-03-31	Flachdichtung
DE202004017327U1 (de)	2005-04-07	Fitnessrad
FR2871686B1 (fr)	2008-02-29	Composition anti-decoloration
DE502005002602D1 (de)	2008-03-13	Fahrzeugtemperiersystem
DE502005004695D1 (de)	2008-08-28	Sicherheitsfangseil
AT500198B8 (de)	2007-02-15	Ladewagen
DE112005000794T5 (de)	2007-05-16	Urethanspritzpistolenanordnung
ATE389633T1 (de)	2008-04-15	Omega-phenyloctanamide
DE502005004160D1 (de)	2008-07-03	Seitenblinkleuchte